Motion to Consolidate Lawsuits Against Ozempic, Wegovy, Other GLP-1 Receptor Agonists Manufacturers To Be Reviewed by MDL Panel
Some plaintiffs are calling for all GLP-1 lawsuits to be consolidated before one judge, while others indicate that any MDL should only include lawsuits against Novo Nordisk, the makers of Ozempic and Wegovy.